12:00 AM
 | 
May 02, 2005
 |  BioCentury  |  Finance

MPM's portfolio

MPM's portfolio

Company Business Region Last MPM round (A) Date Raised MPM directors
Acorda Neurology U.S. ND 5/9/03 $55.3 Michael Steinmetz
Affymax Cancer; Hematology U.S. Series C 6/23/03 $40.0 Nicholas Galakatos
Amphora Chemistry; Genomics U.S. Series C 12/8/04 $20.0 Michael Steinmetz
Arriva Pulmonary; Inflammation; Infectious U.S. Series D 5/6/02 $28.0 Ansbert Gadicke, Edward Mascioli
ARYx Cardiovascular; Gastrointestinal; Chemistry U.S. Series D 6/1/04 $55.0 Nick Simon
Atugen Metabolic; Cancer; Functional genomics Germany Series B

Read the full 641 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >